BioXcel Publishes Study on Dexmedetomidine and Stress Behaviors
August 6, 2025
Leading academic institutions are evaluating BXCL-501 in clinical studies for multiple chronic conditions BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence to develop transformative